4.3 Article

Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut Microbiota Dysbiosis: Study Protocol for a Randomized Controlled Trial

Journal

CURRENT MEDICAL SCIENCE
Volume 41, Issue 6, Pages 1087-1095

Publisher

SPRINGER
DOI: 10.1007/s11596-021-2475-2

Keywords

COVID-19; SARS-Cov-2 virus; gut microbiota; microbiome; dysbiosis; washed microbiota transplantation

Funding

  1. Special Research Project on Prevention and Control of COVID-19 in Universities of the Guangdong Provincial Education Department [2020KZDZX1132]

Ask authors/readers for more resources

This study aims to investigate the efficacy and safety of washed microbiota transplantation (WMT) in COVID-19 patients suspected of gut microbiota dysbiosis (GMD), expecting that WMT can improve intestinal mucosal barrier function, inflammatory response, and immunity.
Objective Coronavirus disease 2019 (COVID-19) is often accompanied by gastrointestinal symptoms, which are related to gut microbiota dysbiosis (GMD). Whether washed microbiota transplantation (WMT) is an effective treatment for COVID-19 patients suspected of having GMD by restoring the gut microbiota is unknown. This study is designed to explore the efficacy and safety of WMT in COVID-19 patients suspected of having GMD. Methods This is a randomized, multicenter, single-blind prospective study. COVID-19 patients suspected of having GMD will be randomly divided to receive routine treatment only or to receive routine treatment and WMT. The frequency of WMT will be once a day for three consecutive days. Laboratory and imaging examinations will be performed at admission, 1 and 2 weeks after treatment, and on the day of discharge. Then a telephone follow-up will be conducted at 1st week, 2nd week, and 6th month after discharge. The clinical efficacy and safety of WMT in COVD-19 patients suspected of having GMD and the effects of WMT on the organ function, homeostasis, inflammatory response, intestinal mucosal barrier function, and immunity of the patients will be evaluated. Results By following the proposed protocol, WMT is expected to be efficacious and safe for the treatment of COVID-19 patients suspected of having GMD, and the therapeutic effect is expected to be associated with improvement of the intestinal mucosal barrier function, inflammatory response, and immunity. Conclusion The findings from this study may offer a new approach for the prevention and treatment of COVID-19 patients suspected of having GMD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available